Physician profile
Lu Chen
NPI 1679935050
$119,207.04
in general payments reported to CMS, 2019-2025
38 companies · $20K in 2025
The $20K reported for 2025 was more than what 89% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,870 · 2020: $1,095 · 2021: $7,564 · 2022: $11K · 2023: $52K · 2024: $26K · 2025: $20K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $50K · Travel and Lodging: $25K · Food and Beverage: $20K · Education: $1,752 · Entertainment: $302.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $50,000.00 |
| Travel and Lodging | $25,292.56 |
| Food and Beverage | $20,133.24 |
| Education | $1,752.40 |
| Entertainment | $301.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $53,396.31 | 2021-2025 | Ensite Precision, Aveir, Ensite |
| Biotronik INC. | $27,015.59 | 2021-2025 | Acticor 7 Vr-T Dx, Biomonitor, Edora 8 Dr-T |
| Boston Scientific Corporation | $16,889.84 | 2019-2025 | Watchman Flx, Resonate El Icd Vr, Emblem Mri S-Icd |
| Medtronic, INC. | $5,917.40 | 2021-2025 | Micra, Selectsecure, Azure Xt Dr Mri Surescan |
| Medical Device Business Services, INC. | $3,306.45 | 2022-2024 | Carto 3 |
| Biosense Webster, INC. | $3,205.55 | 2023-2025 | Carto 3 |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,302.43 | 2019-2025 | Lifevest |
| Cvrx, INC. | $886.35 | 2021-2023 | Barostim Neo System |
| Janssen Pharmaceuticals, INC | $835.61 | 2019-2024 | Xarelto |
| Astrazeneca Pharmaceuticals Lp | $759.72 | 2020-2025 | Lokelma, Farxiga |
| Cardiva Medical, INC. | $731.91 | 2021-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade 6/7f Vcs |
| Atricure, INC. | $695.27 | 2021 | |
| Abiomed | $528.01 | 2021-2025 | |
| Nuwellis, INC. | $454.29 | 2021-2022 | |
| Abbvie INC. | $399.48 | 2019 |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lu Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.